Envista (NYSE:NVST) Given New $23.00 Price Target at JPMorgan Chase & Co.

Envista (NYSE:NVST) had its target price decreased by equities research analysts at JPMorgan Chase & Co. from $29.00 to $23.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 16.34% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research report on Thursday. Robert W. Baird decreased their target price on Envista from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Thursday. Leerink Partnrs reaffirmed an “underperform” rating on shares of Envista in a report on Monday, February 26th. SVB Leerink initiated coverage on Envista in a report on Monday, February 26th. They set an “underperform” rating and a $19.00 price target for the company. Finally, Jefferies Financial Group cut Envista from a “buy” rating to a “hold” rating and reduced their price objective for the company from $30.00 to $23.00 in a research report on Friday, February 9th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $26.27.

Envista Stock Up 0.1 %

NYSE:NVST traded up $0.02 during trading hours on Thursday, reaching $19.77. The company’s stock had a trading volume of 2,134,817 shares, compared to its average volume of 2,298,014. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.23 and a quick ratio of 1.90. The company has a market cap of $3.40 billion, a price-to-earnings ratio of -32.66, a price-to-earnings-growth ratio of 3.72 and a beta of 1.35. Envista has a one year low of $18.09 and a one year high of $38.42. The business’s 50-day moving average is $20.80 and its 200-day moving average is $22.59.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.05). Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The company had revenue of $623.60 million for the quarter, compared to the consensus estimate of $634.85 million. During the same quarter last year, the company posted $0.38 EPS. The business’s revenue was down .6% compared to the same quarter last year. Equities research analysts predict that Envista will post 1.41 EPS for the current year.

Institutional Investors Weigh In On Envista

Several institutional investors and hedge funds have recently bought and sold shares of NVST. Capstone Investment Advisors LLC grew its stake in shares of Envista by 51.3% in the 1st quarter. Capstone Investment Advisors LLC now owns 64,779 shares of the company’s stock valued at $1,385,000 after purchasing an additional 21,950 shares during the period. Principal Financial Group Inc. grew its position in Envista by 2.6% in the first quarter. Principal Financial Group Inc. now owns 645,149 shares of the company’s stock valued at $13,793,000 after acquiring an additional 16,326 shares during the period. Verdence Capital Advisors LLC bought a new stake in Envista in the first quarter valued at $252,000. New York State Teachers Retirement System raised its stake in Envista by 3.8% during the first quarter. New York State Teachers Retirement System now owns 49,991 shares of the company’s stock worth $1,069,000 after acquiring an additional 1,812 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its holdings in shares of Envista by 2.7% during the first quarter. Louisiana State Employees Retirement System now owns 49,400 shares of the company’s stock valued at $1,056,000 after acquiring an additional 1,300 shares during the period.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.